What We’re Reading: FL’s Adult Transgender Restrictions; Weight-Loss Companies Offer Obesity Drugs; Hormone Patches, Creams Lower BP Risk


Health restrictions on transgender adults and children; weight-loss companies to include obesity drugs; hormone patches or creams for menopause may have lower blood pressure risk than pills

Transgender Adults in Florida Shocked by New Gender-affirming Law

Florida's new law signed by Governor Ron DeSantis (R) has not only restricted gender-affirming care for transgender children but has also made it difficult for many transgender adults to access treatment, according to The Associated Press. Transgender adults in Florida felt blindsided when they discovered that the law would limit their access to health care. The law imposes strict regulations, including the requirement of an informed consent form and in-person visits with a physician, while allowing doctors and pharmacists to refuse treatment for transgender individuals.

Weight-loss Companies Shift Business Strategies to Include Obesity Drugs

Due to increased demand, WeightWatchers and Noom are adapting their business models to include prescription medications like Wegovy and Ozempic, according to NBC News. The companies report they are responding to an evolving understanding of obesity as a chronic disease and customer requests for medication options. By offering access to these drugs, they aim to provide more comprehensive solutions for weight loss, acknowledging the limitations of traditional diet and exercise approaches.

Hormone Patches or Creams for Menopause Symptoms Linked to Lower Blood Pressure Risk Compared to Pills

New research indicates that women who use hormone therapy to alleviate menopause symptoms may have a lower risk of high blood pressure if they opt for patches or creams instead of pills, according to ABC News. The study found that those who took estrogen pills had a 14% higher risk of developing hypertension compared to those who used skin patches or creams. While further research is needed to fully understand the relationship between hormone therapy and blood pressure, the findings highlight the importance of monitoring blood pressure in women using oral hormone therapy.

Related Videos
Matthew Crowley, MD, MHS, associate professor of medicine, Duke University School of Medicine.
Dr Seun Ross: Achieving Equity is Necessary to Sustain the Health Care System
Jennifer Sturgill, DO, Central Ohio Primary Care
Kristin Oaks, DO, Central Ohio Primary Care
Donna Fitzsimons
Nick Ferreyros, Community Oncology Alliance
Ryan Haumschild, PharmD, MS, MBA, director of pharmacy, Emory Winship Cancer Institute
Kristine Slam, MD, FACP, Central Ohio Surgical Associates
Milind Desai, MD, MBA
Related Content
© 2023 MJH Life Sciences
All rights reserved.